MedTrace Logo

Brachytherapy in Treating Patients With Recurrent Prostate Cancer

NCT00005939 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL

Last updated 2013-11-06

No results posted yet for this study

Summary

RATIONALE: Radiation therapy uses high-energy radiation to damage tumor cells. Brachytherapy uses radioactive material that is placed directly into or near the tumor. Brachytherapy may kill more tumor cells.

PURPOSE: Phase I/II trial to study the effectiveness of brachytherapy in treating patients who have recurrent prostate cancer that has not responded to standard therapy.

Conditions

Interventions

RADIATION

brachytherapy

RADIATION

phosphorus P32

Sponsors & Collaborators

  • Center for Molecular Medicine

    lead OTHER

Principal Investigators

  • Wayne S. Court, MD, PhD · Center for Molecular Medicine

Study Design

Purpose
TREATMENT

Eligibility

Min Age
21 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00005939 on ClinicalTrials.gov